The Australian Influenza Surveillance Report (AISR) is published on a fortnightly basis during the influenza season, typically between May and October. Influenza activity updates may be published outside of the seasonal period.
Australian Influenza Surveillance Report - 2022 Influenza Season in Australia
Australian Influenza Surveillance Report No 06 - fortnight ending 19 June 2022
It is important to note that due to the COVID-19 epidemic in Australia, data reported from the various influenza surveillance systems may not represent an accurate reflection of influenza activity. Results should be interpreted with caution, especially where comparisons are made to previous influenza seasons. Interpretation of influenza activity data from April 2020 onwards should take into account, but are not limited to, the impact of social distancing measures, likely changes in health seeking behaviour of the community including access to alternative streams of acute respiratory infection specific health services, and focussed testing for COVID-19 response activities. For information on COVID-19 incidence, severity, and distribution in Australia, please refer to COVID-19 epidemiology reports.
- Influenza-like-illness (ILI) activity in the community this year has increased since March 2022.
- In the year to date in 2022, there have been 147,155 notifications reported to the National Notifiable Diseases Surveillance System (NNDSS) in Australia, of which 55,101 notifications had a diagnosis date this fortnight.
- From mid-April 2022, the weekly number of notifications of laboratory-confirmed influenza reported in Australia has exceeded the 5 year average.
- In the year to date, of the 147,155 notifications of laboratory-confirmed influenza, 54 influenza-associated deaths have been notified to the NNDSS.
- Since commencement of seasonal surveillance in April 2022, there have been 989 hospital admissions due to influenza reported across sentinel hospitals sites, of which 6.1% were admitted directly to ICU.
- There is no indication of the potential impact of the 2022 season on society at this time.
- In 2022 to date, people aged 5–9 years, children aged younger than 5 years, and people aged 10–19 years have the highest notification rates.
- To date, 83.4% of notifications of laboratory-confirmed influenza reported to the NNDSS were influenza A, of which 94.8% were influenza A(unsubtyped), 0.8% were influenza A(H1N1), and 4.4% were influenza A(H3N2). Influenza B accounted for 0.1% of notifications, less than 0.1% were A&B co-infections, and 16.5% were untyped.
Vaccine match and effectiveness
- Of the 1,041 samples referred to the WHOCC to date, 98.8% of influenza A(H1N1), 96.1% of influenza A(H3N2), and the influenza B/Victoria sample, were characterised as antigenically similar to the corresponding vaccine components.
- It is too early to assess vaccine match and effectiveness for this season.
NNDSS laboratory-confirmed influenza case definition – Technical Supplement
From 01 January 2022, the NNDSS case definition for laboratory-confirmed influenza was updated. For an overview of the case definition update, analyses of the impact of this change in case definition, and explanation of how data will be presented in influenza reports going forward, please refer to the NNDSS laboratory-confirmed influenza case definition Technical Supplement:
The AISR aims to increase awareness of influenza activity in Australia by providing an analysis of the various surveillance data sources throughout Australia. While every care has been taken in preparing this report, the Commonwealth does not accept liability for any injury or loss or damage arising from the use of, or reliance upon, the content of the report. Delays in the reporting of data may cause data to change retrospectively. For further details about information contained in this report please refer to the AISR 2020 Data Consideration:
Influenza vaccine efficacy, effectiveness and impact explained
There are three general terms that are used to describe how well a vaccine works in any given influenza season: vaccine efficacy, vaccine effectiveness and vaccine impact. This document provides a general explanation of each of these terms as well as information specific to influenza vaccines.
top of page
Previous Reports and Updates
State and Territory Surveillance Reports
For further information regarding current influenza activity at the jurisdictional level, please refer to the following State and Territory departments of health surveillance reports:
National Influenza Surveillance Scheme
This paper provides a comprehensive summary and analysis of the National Influenza Surveillance Scheme, including surveillance systems that function outside of the Scheme, in 2015. The Scheme is coordinated by the Australian Government Department of Health and supported by a number of surveillance systems that aim to be nationally representative and monitor important aspects of severity, incidence and virology. Influenza activity monitored through its systems is presented in reports available on this page. Several jurisdictionally based surveillance systems that operate outside of the Scheme are used to inform local influenza activity trends. This paper describes the strengths and limitations of these influenza surveillance systems in terms of the aspects of influenza activity that they inform and their contribution to the overall monitoring of influenza activity in Australia.
Should you encounter issues in accessing the information contained either on this webpage or within the downloadable full reports please email flu (email@example.com) or contact the Department of Health switchboard on 02 6289 1555 or 1800 020 103.
top of page